An Invitation to Complementary and I ntegrative Health Researchers To Add ress Deprescribing of Benzodiazepine s; Teaming Event on November 9, 2022

October 27, 2022
Pete Murray, Ph.D.

TheUS Deprescribing Research Network (USDeN), a network of researchers funded by the National Institute on Aging, is united by a shared interest in improving research on deprescribing for older adults. The USDeN has an exciting new initiative for pilot studies of interventions that use complementaryand integrative health approaches to support deprescribing of benzodiazepines.Benzodiazepines are a class of psychiatric drugs approved to treat generalized anxiety disorder, insomnia, seizures, social phobia, and panic disorder. While benzodiazepines have been shown to have efficacy in treating these conditions, there are considerable risks associated with benzodiazepine use including abuse, misuse, and addiction.

Read the full post and comment